Takeda
Takeda is a global pharmaceutical company with a focus on various therapeutic areas and a commitment to sustainability, aiming to become carbon neutral by 2040.
Manufacturing Sites
Takeda operates more than 25 manufacturing sites worldwide. These facilities are involved in the production of a wide range of pharmaceutical products, including small molecules, biologics, plasma-derived products, vaccines, and cell therapy. This global manufacturing footprint allows Takeda to meet the diverse and evolving healthcare needs of patients across various regions.
Therapeutic Areas
Takeda focuses on several key therapeutic areas: gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience, and vaccines. These areas are central to Takeda's mission of delivering better health and a brighter future for patients worldwide.
Sustainability Goals
Takeda is committed to sustainability and has set a target to become carbon neutral by 2040. This includes a goal of reducing Scope 3 emissions by 50%. Takeda's dedication to environmental stewardship is a core part of its broader corporate responsibility objectives.
Ethical Sourcing and Supplier Management
Takeda engages in ethical sourcing and robust supplier risk management. The company assesses approximately 41,000 suppliers globally to ensure responsible practices and mitigate risks. This thorough process supports Takeda's commitment to sustainability and corporate social responsibility.
Global CSR Program
Takeda's Global CSR Program supports activities aimed at disease prevention, health worker training, and improving access to quality diagnosis and treatment in developing and emerging countries. These efforts are part of Takeda's broader commitment to social responsibility and improving healthcare outcomes globally.
Patient Assistance Program
Takeda provides a Patient Assistance Program to improve access to medicines for patients in low- and middle-income countries. This initiative helps ensure that essential treatments are available to patients who might otherwise be unable to afford them, aligning with Takeda's mission of enhancing patient care and health equity.
Organizational Agility and Technological Capabilities
Takeda is utilizing a multi-year program to enhance organizational agility, streamline spending efficiencies, and leverage capabilities in data, digital, and technology. This program is aimed at reinforcing Takeda's operational effectiveness and ability to respond to changing market conditions.
Financial Performance and Outlook
Takeda announced its financial results for the fiscal year 2023 and provided an outlook for 2024. The company is focusing on late-stage pipeline development and core operating profit margin expansion. These strategic priorities are designed to drive Takeda's growth and long-term financial sustainability.